The evolving landscape in advanced penile cancer
- PMID: 28031884
- PMCID: PMC5137911
- DOI: 10.4155/fso.15.7
The evolving landscape in advanced penile cancer
Keywords: chemotherapy; immunotherapy; penile cancer; targeted therapy.
Conflict of interest statement
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
References
-
- Novara G, Galfano A, De Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat. Clin. Pract. Urol. 2007;4(3):140–146. - PubMed
-
- Djajadiningrat RS, Graafland NM, van Werkhoven E, et al. Contemporary management of regional nodes in penile cancer-improvement of survival? J. Urol. 2014;191(1):68–73. - PubMed
-
- Chen MF, Chen WC, Wu CT, Chuang CK, Ng KF, Chang JT. Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan. World J. Urol. 2004;22(1):60–66. - PubMed